Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Research
Alternate history of NIH reveals potential impact of agency cuts
If the NIH budget had been 40% smaller from 1980 to 2007, the science underlying many drugs approved in the 21st century would not have been funded.
Darren Incorvaia
Sep 25, 2025 2:00pm
Sponsored
Getting to Yes: How Deal-Making Fuels Biotech Growth
Sep 17, 2025 3:20pm
Lilly withdraws phase 2 obesity trial before starting enrollment
Sep 25, 2025 8:07am
Trump administration launches tariff probe into medtech industry
Sep 25, 2025 2:30pm
NIH earmarks $87M for new organoid center
Sep 25, 2025 11:55am
Fierce Biotech's 2025 Fierce 15
Sep 22, 2025 8:00am
More News
Sequel, Arecor to explore ultraconcentrated insulin delivery
Sep 25, 2025 1:00pm
Fierce Healthcare
White House preps for mass firings amid potential shutdown
Sep 25, 2025 11:00am
Heidelberg to ax 75% of staff after milestone becomes millstone
Sep 25, 2025 7:20am
Merck opts in on Evaxian's preclinical vaccine candidate
Sep 25, 2025 7:00am
See more stories